The problem is this.....

we are already dealing with small samples in phase 3 especially amongst minorities who were underrepresented in some cases.

I fully understand the extrapolating of data, and it may prove eventually to be correct.

But do we have enough data to state 0.5 Y deaths with one dose?

Science is about the repeatability of results. Hard to do when you change the variables every few weeks.
We should follow the science as we know it.

It also makes it harder to collect long term data if different people are getting different procedures.

Posted By: usacanary on January 1st 2021 at 20:21:56

Message Thread

US breaks from the UK in Vaccine approach... (Coronavirus) - usacanary, Jan 1, 18:52:22
- I think the underlying issue is the same from both AZ and BioNtech (Coronavirus) - Timmy_Goat, Jan 1, 19:52:22
  - The problem is this..... (Coronavirus) - usacanary, Jan 1, 20:21:56
- No the U.K. broke from Pfizer (Coronavirus) - SCC 28, Jan 1, 19:04:43
- U.K. will predominantly be using oxford vaccine from this point forwards though (n/m) (Coronavirus) - loz, Jan 1, 19:00:58
  - And they’re changing from the trials there too (Coronavirus) - SCC 28, Jan 1, 19:07:42
    - Didn’t some of the more recent studies for the Oxford vaccine ... (Coronavirus) - loz, Jan 1, 19:14:31
      - For the Oxford one, yes. However, none at all for the Pfizer one (n/m) (Coronavirus) - woody, Jan 1, 23:15:38
      - There’s data but unpublished (Coronavirus) - SCC 28, Jan 1, 19:21:52

Reply to Message

In order to add a post to the WotB Message Board you must be a registered WotB user.

If you are not yet registered then please visit the registration page. You should ensure that their browser is setup to accept cookies.